Botox® Cosmetic and Botox® (Botulinum Toxin Type A) By the Numbers
13,000,000: Aesthetic procedures with Botox® Cosmetic have been administered to date.
3,181,592: Number of Botox® Cosmetic treatments administered in the United States in 2006 alone.
1,000,000: People who received treatment with Botox® for medical and aesthetic purposes around the world.
300,000: Number of men who received treatment with Botox® Cosmetic in 2006.
3,000: Publications on Botulinum Toxin Type A in scientific and medical journals.
100: Years of study into botulinum neurotoxins.
97: Percentage of people satisfied with their Botox® Cosmetic treatment based on a survey of approximately 1,000 patients.
75: Countries around the world who have approved use of Botox®.
20: Botox® indications approved by regulatory authorities around the world, including aesthetic indication.
18: Years since U.S. Food and Drug Administration (FDA) approved Botox® to treat excessive eye blinking and crossed eyes.
11: Descriptor for the glabellar (vertical) lines between the brows which can be treated with Botox® Cosmetic, that can help improve one's overall facial appearance.
8: Years since FDA approval of Botox® for the treatment of cervical dystonia (painful neck twisting condition) in adults.
6: Years since FDA approval of Botox® Cosmetic for the treatment of the moderate to severe glabellar (vertical) lines between the brows, forehead and crow's feet in adults 18 to 65.
4: Years since FDA approval of Botox® Cosmetic for the treatment of severe primary hyperhidrosis (excessive underarm sweating) inadequately managed with topical agents.
1: Rank of Botox® Cosmetic on list of "Top 5 Surgical & Nonsurgical Physician Administered Cosmetic Procedures," according to American Society for Aesthetic Plastic Surgery.
